@FiercePharma: ICYMI: Merck's Keytruda gets FDA approval for NSCLC ahead of BMS' Opdivo but label is limited. Article | Follow @FiercePharma
@EricPFierce: Swiss CMO Seigfried completes $302M deal for BASF API plants. FiercePharmaManufacturing story | Follow @EricPFierce
@CarlyHFierce: ICYMI: Ackman's fund takes a beating on Valeant pricing worries. Item | Follow @CarlyHFierce
> Though Horizon Pharma ($HZNP) is technically based in Ireland, its U.S. headquarters is where the action is, and the company is tripling the size of that operation with a move to Lake Forest, IL, from nearby Deerfield. Report
> The U.K.'s Medicines and Healthcare Regulatory Agency is joining forces with its Indian counterpart in a pact to collaborate on overseeing the drug and device business in their respective countries. Report
> India's Biocon saw its shares rise by 2% after announcing it would buy a manufacturing unit from another Indian company, Acacia Life Sciences. Report
> Pfizer ($PFE) wrapped up its $130 million buyout of two GlaxoSmithKline ($GSK) meningococcal vaccines, Nimenrix and Mencevax. Report
> Indivior plans to sue Novartis' ($NVS) generics unit Sandoz for patent infringement after the latter filed for FDA approval for a copycat version of suboxone sublingual film. Report
Medical Device News
@FierceMedDev: ICYMI Friday: Investigational spinal cord implant bringing bodily sensation back to the lives of the paralyzed. Report | Follow @FierceMedDev
@EmilyWFierce: ICYMI from FiercePharma: FTC weighs in on Mylan case, saying generics tweaking may be anticompetitive. Story | Follow @EmilyWFierce
> Boston Scientific wins $200M stent patent infringement case against doctor. Report
> Europe grants its first CE mark for leadless pacemaker to treat left ventricle. Article
Biotech News
@FierceBiotech: Spark soars on success of gene therapy study, shot at groundbreaking approval. Report | Follow @FierceBiotech
@JohnCFierce: That Shkreli scandal? Infecting Valeant and Mike Pearson as the industry runs away as fast as possible. New York Times article | Follow @JohnCFierce
> Trans-Pacific trade pact compromises on drug exclusivity with 5- to 8-year haven. Story
> Baxalta and Momenta target Humira with a Phase III biosimilar trial. Article
Animal Health News
> International health groups vow renewed effort to eradicate rabies. Report
> FDA seeks veterinarians' input on antibiotics resistance. Item
> USDA: Deadly pig virus likely carried into U.S. from China. More
> Stem cell treatment proves promising in dogs with Crohn's-like disease. Article
> WHO chief Margaret Chan vows to boost preparedness for disease outbreaks. Story
Biotech IT News
> Mount Sinai, Yale roll out updates to Apple ResearchKit programs. Report
> Allergan taps NuMedii's digital discovery platform for psoriasis R&D. News
> Illumina readies paid-for BaseSpace tiers for large organizations. More
> Cloud Pharmaceuticals, Therametrics hook up for CNS drug discovery drive. Story
> Berg to apply AI drug discovery model to U.K.'s genome data repository. Article
Pharma Marketing News
> BioMarin eyes SG&A efficiency on Kuvan; no worries on rare-disease pricing. Item
> Want to get a warning letter from OPDP? Omit drug risks from your promos. Story
> Teva snaps up Gecko and its 'smart inhaler' to pump up respiratory meds. More
> Veeva scoops up rival Zinc Ahead to create mega-content management platform. Report
> Obstacles aside, Boehringer sees class-topping prospects for Ofev, Spiolto. Article
And Finally... A Chinese biotech company says it has solved a vexing problem: Keeping pigs to housepet size. Report